1. Home
  2. LTC vs GHRS Comparison

LTC vs GHRS Comparison

Compare LTC & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LTC Properties Inc.

LTC

LTC Properties Inc.

SELL

Current Price

$43.34

Market Cap

2.3B

Sector

Real Estate

ML Signal

SELL

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$18.79

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTC
GHRS
Founded
1992
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
LTC
GHRS
Price
$43.34
$18.79
Analyst Decision
Hold
Strong Buy
Analyst Count
8
10
Target Price
★ $45.86
$42.89
AVG Volume (30 Days)
★ 576.0K
293.8K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
★ 5.28%
N/A
EPS Growth
★ 23.53
N/A
EPS
★ 1.05
N/A
Revenue
★ $262,854,000.00
N/A
Revenue This Year
$66.77
N/A
Revenue Next Year
$47.98
N/A
P/E Ratio
$41.14
★ N/A
Revenue Growth
★ 25.26
N/A
52 Week Low
$33.64
$12.04
52 Week High
$43.60
$31.44

Technical Indicators

Market Signals
Indicator
LTC
GHRS
Relative Strength Index (RSI) 60.43 23.29
Support Level $37.66 $13.58
Resistance Level N/A $22.88
Average True Range (ATR) 0.73 1.16
MACD -0.00 -0.37
Stochastic Oscillator 72.43 7.16

Price Performance

Historical Comparison
LTC
GHRS

About LTC LTC Properties Inc.

LTC Properties Inc is a real estate investment trust. It invests in seniors housing and health care properties, mainly through ownership, sale-leasebacks, mortgage financing, joint ventures, construction financing, and structured finance solutions, including preferred equity, bridge, and mezzanine lending. The company's investment portfolio comprises several properties located throughout the USA, the majority of which are seniors housing and skilled nursing properties. The firm conducts and manages its business as two operating segments: Real Estate Investments, which generates maximum revenue, and SHOP.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: